iMDK (quarterhydrate) - HY-110171A
Nur noch %1 verfügbar
Catalog #
HY-110171A
Ab
165,00 €
iMDK quarterhydrate is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-110171A/iMDK-quarterhydrate-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 380.91 |
| Solubility | DMSO : 3.33 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | PI3K |
| Application: | Cancer-Kinase/protease |
|---|